The Therapeutic Nuclear Medicines market has witnessed growth from USD XX million to USD XX million from 2017 to 2022. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2029.
The report focuses on the Therapeutic Nuclear Medicines market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides detailed cost analysis, supply chain.
Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Consumer behavior analysis and market dynamics (drivers, restraints, opportunities) provides crucial information for knowing the Therapeutic Nuclear Medicines market.
Key players in the global Therapeutic Nuclear Medicines market covered in Chapter 2 and Chapter 6:
Acrotech Biopharma.
China Isotope and Radiation
Progenics Pharmaceuticals
Novartis AG
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Bayer
Lantheus
International Isotopes
Dongcheng
In Chapter 8 and Chapter 10.3, based on types, the Therapeutic Nuclear Medicines market from 2017 to 2029 is primarily split into:
Radium-223
Lutetium-177
Iodine-131
Other
In Chapter 9 and Chapter 10.4, based on applications, the Therapeutic Nuclear Medicines market from 2017 to 2029 covers:
Thyroid
Bone Metastasis
Lymphoma
Other
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2017 -2029) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Latin America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions
Chapter 1 provides an overview of Therapeutic Nuclear Medicines market, containing global revenue and CAGR. The forecast and analysis of Therapeutic Nuclear Medicines market by type, application, and region are also presented in this chapter.
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 introduces the industrial chain of Therapeutic Nuclear Medicines. Industrial chain analysis, raw material (suppliers, price, supply and demand, market concentration rate) and downstream buyers are analyzed in this chapter.
Chapter 4 concentrates on manufacturing analysis, including cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 5 provides clear insights into market dynamics, the influence of COVID-19 in Therapeutic Nuclear Medicines industry, consumer behavior analysis.
Chapter 6 provides a full-scale analysis of major players in Therapeutic Nuclear Medicines industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 7 pays attention to the sales, revenue, price and gross margin of Therapeutic Nuclear Medicines in markets of different regions. The analysis on sales, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 gives a worldwide view of Therapeutic Nuclear Medicines market. It includes sales, revenue, price, market share and the growth rate by type.
Chapter 9 focuses on the application of Therapeutic Nuclear Medicines, by analyzing the consumption and its growth rate of each application.
Chapter 10 prospects the whole Therapeutic Nuclear Medicines market, including the global sales and revenue forecast, regional forecast. It also foresees the Therapeutic Nuclear Medicines market by type and application.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
Table of Content
1 Therapeutic Nuclear Medicines Market Overview
1.1 Product Overview and Scope of Therapeutic Nuclear Medicines
1.2 Therapeutic Nuclear Medicines Segment by Type
1.2.1 Global Therapeutic Nuclear Medicines Sales and CAGR (%) Comparison by Type (2017-2029)
1.2.2 The Market Profile of Radium-223
1.2.3 The Market Profile of Lutetium-177
1.2.4 The Market Profile of Iodine-131
1.2.5 The Market Profile of Other
1.3 Global Therapeutic Nuclear Medicines Segment by Application
1.3.1 Therapeutic Nuclear Medicines Consumption (Sales) Comparison by Application (2017-2029)
1.3.2 The Market Profile of Thyroid
1.3.3 The Market Profile of Bone Metastasis
1.3.4 The Market Profile of Lymphoma
1.3.5 The Market Profile of Other
1.4 Global Therapeutic Nuclear Medicines Market, Region Wise (2017-2022)
1.4.1 Global Therapeutic Nuclear Medicines Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2022)
1.4.2 United States Therapeutic Nuclear Medicines Market Status and Prospect (2017-2022)
1.4.3 Europe Therapeutic Nuclear Medicines Market Status and Prospect (2017-2022)
1.4.3.1 Germany Therapeutic Nuclear Medicines Market Status and Prospect (2017-2022)
1.4.3.2 UK Therapeutic Nuclear Medicines Market Status and Prospect (2017-2022)
1.4.3.3 France Therapeutic Nuclear Medicines Market Status and Prospect (2017-2022)
1.4.3.4 Italy Therapeutic Nuclear Medicines Market Status and Prospect (2017-2022)
1.4.3.5 Spain Therapeutic Nuclear Medicines Market Status and Prospect (2017-2022)
1.4.3.6 Russia Therapeutic Nuclear Medicines Market Status and Prospect (2017-2022)
1.4.3.7 Poland Therapeutic Nuclear Medicines Market Status and Prospect (2017-2022)
1.4.4 China Therapeutic Nuclear Medicines Market Status and Prospect (2017-2022)
1.4.5 Japan Therapeutic Nuclear Medicines Market Status and Prospect (2017-2022)
1.4.6 India Therapeutic Nuclear Medicines Market Status and Prospect (2017-2022)
1.4.7 Southeast Asia Therapeutic Nuclear Medicines Market Status and Prospect (2017-2022)
1.4.7.1 Malaysia Therapeutic Nuclear Medicines Market Status and Prospect (2017-2022)
1.4.7.2 Singapore Therapeutic Nuclear Medicines Market Status and Prospect (2017-2022)
1.4.7.3 Philippines Therapeutic Nuclear Medicines Market Status and Prospect (2017-2022)
1.4.7.4 Indonesia Therapeutic Nuclear Medicines Market Status and Prospect (2017-2022)
1.4.7.5 Thailand Therapeutic Nuclear Medicines Market Status and Prospect (2017-2022)
1.4.7.6 Vietnam Therapeutic Nuclear Medicines Market Status and Prospect (2017-2022)
1.4.8 Latin America Therapeutic Nuclear Medicines Market Status and Prospect (2017-2022)
1.4.8.1 Brazil Therapeutic Nuclear Medicines Market Status and Prospect (2017-2022)
1.4.8.2 Mexico Therapeutic Nuclear Medicines Market Status and Prospect (2017-2022)
1.4.8.3 Colombia Therapeutic Nuclear Medicines Market Status and Prospect (2017-2022)
1.4.9 Middle East and Africa Therapeutic Nuclear Medicines Market Status and Prospect (2017-2022)
1.4.9.1 Saudi Arabia Therapeutic Nuclear Medicines Market Status and Prospect (2017-2022)
1.4.9.2 United Arab Emirates Therapeutic Nuclear Medicines Market Status and Prospect (2017-2022)
1.4.9.3 Turkey Therapeutic Nuclear Medicines Market Status and Prospect (2017-2022)
1.4.9.4 Egypt Therapeutic Nuclear Medicines Market Status and Prospect (2017-2022)
1.4.9.5 South Africa Therapeutic Nuclear Medicines Market Status and Prospect (2017-2022)
1.4.9.6 Nigeria Therapeutic Nuclear Medicines Market Status and Prospect (2017-2022)
1.5 Global Market Size of Therapeutic Nuclear Medicines (2017-2029)
1.5.1 Global Therapeutic Nuclear Medicines Revenue Status and Outlook (2017-2029)
1.5.2 Global Therapeutic Nuclear Medicines Sales Status and Outlook (2017-2029)
2 Global Therapeutic Nuclear Medicines Market Landscape by Player
2.1 Global Therapeutic Nuclear Medicines Sales and Share by Player (2017-2022)
2.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Player (2017-2022)
2.3 Global Therapeutic Nuclear Medicines Average Price by Player (2017-2022)
2.4 Global Therapeutic Nuclear Medicines Gross Margin by Player (2017-2022)
2.5 Therapeutic Nuclear Medicines Manufacturing Base Distribution, Sales Area and Product Type by Player
2.6 Therapeutic Nuclear Medicines Market Competitive Situation and Trends
2.6.1 Therapeutic Nuclear Medicines Market Concentration Rate
2.6.2 Therapeutic Nuclear Medicines Market Share of Top 3 and Top 6 Players
2.6.3 Mergers & Acquisitions, Expansion
3 Therapeutic Nuclear Medicines Upstream and Downstream Analysis
3.1 Therapeutic Nuclear Medicines Industrial Chain Analysis
3.2 Key Raw Materials Suppliers and Price Analysis
3.3 Key Raw Materials Supply and Demand Analysis
3.4 Manufacturing Process Analysis
3.5 Market Concentration Rate of Raw Materials
3.6 Downstream Buyers
3.7 Value Chain Status Under COVID-19
4 Therapeutic Nuclear Medicines Manufacturing Cost Analysis
4.1 Manufacturing Cost Structure Analysis
4.2 Therapeutic Nuclear Medicines Key Raw Materials Cost Analysis
4.2.1 Key Raw Materials Introduction
4.2.2 Price Trend of Key Raw Materials
4.3 Labor Cost Analysis
4.3.1 Labor Cost of Therapeutic Nuclear Medicines Under COVID-19
4.4 Energy Costs Analysis
4.5 R&D Costs Analysis
5 Market Dynamics
5.1 Drivers
5.2 Restraints and Challenges
5.3 Opportunities
5.3.1 Advances in Innovation and Technology for Therapeutic Nuclear Medicines
5.3.2 Increased Demand in Emerging Markets
5.4 Therapeutic Nuclear Medicines Industry Development Trends under COVID-19 Outbreak
5.4.1 Global COVID-19 Status Overview
5.4.2 Influence of COVID-19 Outbreak on Therapeutic Nuclear Medicines Industry Development
5.5 Consumer Behavior Analysis
6 Players Profiles
6.1 Acrotech Biopharma.
6.1.1 Acrotech Biopharma. Basic Information, Manufacturing Base, Sales Area and Competitors
6.1.2 Therapeutic Nuclear Medicines Product Profiles, Application and Specification
6.1.3 Acrotech Biopharma. Therapeutic Nuclear Medicines Market Performance (2017-2022)
6.1.4 Acrotech Biopharma. Business Overview
6.2 China Isotope and Radiation
6.2.1 China Isotope and Radiation Basic Information, Manufacturing Base, Sales Area and Competitors
6.2.2 Therapeutic Nuclear Medicines Product Profiles, Application and Specification
6.2.3 China Isotope and Radiation Therapeutic Nuclear Medicines Market Performance (2017-2022)
6.2.4 China Isotope and Radiation Business Overview
6.3 Progenics Pharmaceuticals
6.3.1 Progenics Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
6.3.2 Therapeutic Nuclear Medicines Product Profiles, Application and Specification
6.3.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Market Performance (2017-2022)
6.3.4 Progenics Pharmaceuticals Business Overview
6.4 Novartis AG
6.4.1 Novartis AG Basic Information, Manufacturing Base, Sales Area and Competitors
6.4.2 Therapeutic Nuclear Medicines Product Profiles, Application and Specification
6.4.3 Novartis AG Therapeutic Nuclear Medicines Market Performance (2017-2022)
6.4.4 Novartis AG Business Overview
6.5 Q BioMed
6.5.1 Q BioMed Basic Information, Manufacturing Base, Sales Area and Competitors
6.5.2 Therapeutic Nuclear Medicines Product Profiles, Application and Specification
6.5.3 Q BioMed Therapeutic Nuclear Medicines Market Performance (2017-2022)
6.5.4 Q BioMed Business Overview
6.6 Curium Pharmaceuticals
6.6.1 Curium Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
6.6.2 Therapeutic Nuclear Medicines Product Profiles, Application and Specification
6.6.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Market Performance (2017-2022)
6.6.4 Curium Pharmaceuticals Business Overview
6.7 Jubilant DraxImage
6.7.1 Jubilant DraxImage Basic Information, Manufacturing Base, Sales Area and Competitors
6.7.2 Therapeutic Nuclear Medicines Product Profiles, Application and Specification
6.7.3 Jubilant DraxImage Therapeutic Nuclear Medicines Market Performance (2017-2022)
6.7.4 Jubilant DraxImage Business Overview
6.8 Bayer
6.8.1 Bayer Basic Information, Manufacturing Base, Sales Area and Competitors
6.8.2 Therapeutic Nuclear Medicines Product Profiles, Application and Specification
6.8.3 Bayer Therapeutic Nuclear Medicines Market Performance (2017-2022)
6.8.4 Bayer Business Overview
6.9 Lantheus
6.9.1 Lantheus Basic Information, Manufacturing Base, Sales Area and Competitors
6.9.2 Therapeutic Nuclear Medicines Product Profiles, Application and Specification
6.9.3 Lantheus Therapeutic Nuclear Medicines Market Performance (2017-2022)
6.9.4 Lantheus Business Overview
6.10 International Isotopes
6.10.1 International Isotopes Basic Information, Manufacturing Base, Sales Area and Competitors
6.10.2 Therapeutic Nuclear Medicines Product Profiles, Application and Specification
6.10.3 International Isotopes Therapeutic Nuclear Medicines Market Performance (2017-2022)
6.10.4 International Isotopes Business Overview
6.11 Dongcheng
6.11.1 Dongcheng Basic Information, Manufacturing Base, Sales Area and Competitors
6.11.2 Therapeutic Nuclear Medicines Product Profiles, Application and Specification
6.11.3 Dongcheng Therapeutic Nuclear Medicines Market Performance (2017-2022)
6.11.4 Dongcheng Business Overview
7 Global Therapeutic Nuclear Medicines Sales and Revenue Region Wise (2017-2022)
7.1 Global Therapeutic Nuclear Medicines Sales and Market Share, Region Wise (2017-2022)
7.2 Global Therapeutic Nuclear Medicines Revenue (Revenue) and Market Share, Region Wise (2017-2022)
7.3 Global Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2022)
7.4.1 United States Therapeutic Nuclear Medicines Market Under COVID-19
7.5 Europe Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2022)
7.5.1 Europe Therapeutic Nuclear Medicines Market Under COVID-19
7.6 China Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2022)
7.6.1 China Therapeutic Nuclear Medicines Market Under COVID-19
7.7 Japan Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2022)
7.7.1 Japan Therapeutic Nuclear Medicines Market Under COVID-19
7.8 India Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2022)
7.8.1 India Therapeutic Nuclear Medicines Market Under COVID-19
7.9 Southeast Asia Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2022)
7.9.1 Southeast Asia Therapeutic Nuclear Medicines Market Under COVID-19
7.10 Latin America Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2022)
7.10.1 Latin America Therapeutic Nuclear Medicines Market Under COVID-19
7.11 Middle East and Africa Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2022)
7.11.1 Middle East and Africa Therapeutic Nuclear Medicines Market Under COVID-19
8 Global Therapeutic Nuclear Medicines Sales, Revenue (Revenue), Price Trend by Type
8.1 Global Therapeutic Nuclear Medicines Sales and Market Share by Type (2017-2022)
8.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Type (2017-2022)
8.3 Global Therapeutic Nuclear Medicines Price by Type (2017-2022)
8.4 Global Therapeutic Nuclear Medicines Sales Growth Rate by Type (2017-2022)
8.4.1 Global Therapeutic Nuclear Medicines Sales Growth Rate of Radium-223 (2017-2022)
8.4.2 Global Therapeutic Nuclear Medicines Sales Growth Rate of Lutetium-177 (2017-2022)
8.4.3 Global Therapeutic Nuclear Medicines Sales Growth Rate of Iodine-131 (2017-2022)
8.4.4 Global Therapeutic Nuclear Medicines Sales Growth Rate of Other (2017-2022)
9 Global Therapeutic Nuclear Medicines Market Analysis by Application
9.1 Global Therapeutic Nuclear Medicines Consumption and Market Share by Application (2017-2022)
9.2 Global Therapeutic Nuclear Medicines Consumption Growth Rate by Application (2017-2022)
9.2.1 Global Therapeutic Nuclear Medicines Consumption Growth Rate of Thyroid (2017-2022)
9.2.2 Global Therapeutic Nuclear Medicines Consumption Growth Rate of Bone Metastasis (2017-2022)
9.2.3 Global Therapeutic Nuclear Medicines Consumption Growth Rate of Lymphoma (2017-2022)
9.2.4 Global Therapeutic Nuclear Medicines Consumption Growth Rate of Other (2017-2022)
10 Global Therapeutic Nuclear Medicines Market Forecast (2022-2029)
10.1 Global Therapeutic Nuclear Medicines Sales, Revenue Forecast (2022-2029)
10.1.1 Global Therapeutic Nuclear Medicines Sales and Growth Rate Forecast (2022-2029)
10.1.2 Global Therapeutic Nuclear Medicines Revenue and Growth Rate Forecast (2022-2029)
10.1.3 Global Therapeutic Nuclear Medicines Price and Trend Forecast (2022-2029)
10.2 Global Therapeutic Nuclear Medicines Sales and Revenue Forecast, Region Wise (2022-2029)
10.2.1 United States Therapeutic Nuclear Medicines Sales and Revenue Forecast (2022-2029)
10.2.2 Europe Therapeutic Nuclear Medicines Sales and Revenue Forecast (2022-2029)
10.2.3 China Therapeutic Nuclear Medicines Sales and Revenue Forecast (2022-2029)
10.2.4 Japan Therapeutic Nuclear Medicines Sales and Revenue Forecast (2022-2029)
10.2.5 India Therapeutic Nuclear Medicines Sales and Revenue Forecast (2022-2029)
10.2.6 Southeast Asia Therapeutic Nuclear Medicines Sales and Revenue Forecast (2022-2029)
10.2.7 Latin America Therapeutic Nuclear Medicines Sales and Revenue Forecast (2022-2029)
10.2.8 Middle East and Africa Therapeutic Nuclear Medicines Sales and Revenue Forecast (2022-2029)
10.3 Global Therapeutic Nuclear Medicines Sales, Revenue and Price Forecast by Type (2022-2029)
10.4 Global Therapeutic Nuclear Medicines Consumption Forecast by Application (2022-2029)
10.5 Therapeutic Nuclear Medicines Market Forecast Under COVID-19
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Data Source
List of Tables and Figures
Figure Therapeutic Nuclear Medicines Product Picture
Table Global Therapeutic Nuclear Medicines Sales and CAGR (%) Comparison by Type
Table Profile of Radium-223
Table Profile of Lutetium-177
Table Profile of Iodine-131
Table Profile of Other
Table Therapeutic Nuclear Medicines Consumption (Sales) Comparison by Application (2017-2029)
Table Profile of Thyroid
Table Profile of Bone Metastasis
Table Profile of Lymphoma
Table Profile of Other
Figure Global Therapeutic Nuclear Medicines Market Size (Revenue) and CAGR (%) (2017-2022)
Figure United States Therapeutic Nuclear Medicines Revenue and Growth Rate (2017-2022)
Figure Europe Therapeutic Nuclear Medicines Revenue and Growth Rate (2017-2022)
Figure Germany Therapeutic Nuclear Medicines Revenue and Growth Rate (2017-2022)
Figure UK Therapeutic Nuclear Medicines Revenue and Growth Rate (2017-2022)
Figure France Therapeutic Nuclear Medicines Revenue and Growth Rate (2017-2022)
Figure Italy Therapeutic Nuclear Medicines Revenue and Growth Rate (2017-2022)
Figure Spain Therapeutic Nuclear Medicines Revenue and Growth Rate (2017-2022)
Figure Russia Therapeutic Nuclear Medicines Revenue and Growth Rate (2017-2022)
Figure Poland Therapeutic Nuclear Medicines Revenue and Growth Rate (2017-2022)
Figure China Therapeutic Nuclear Medicines Revenue and Growth Rate (2017-2022)
Figure Japan Therapeutic Nuclear Medicines Revenue and Growth Rate (2017-2022)
Figure India Therapeutic Nuclear Medicines Revenue and Growth Rate (2017-2022)
Figure Southeast Asia Therapeutic Nuclear Medicines Revenue and Growth Rate (2017-2022)
Figure Malaysia Therapeutic Nuclear Medicines Revenue and Growth Rate (2017-2022)
Figure Singapore Therapeutic Nuclear Medicines Revenue and Growth Rate (2017-2022)
Figure Philippines Therapeutic Nuclear Medicines Revenue and Growth Rate (2017-2022)
Figure Indonesia Therapeutic Nuclear Medicines Revenue and Growth Rate (2017-2022)
Figure Thailand Therapeutic Nuclear Medicines Revenue and Growth Rate (2017-2022)
Figure Vietnam Therapeutic Nuclear Medicines Revenue and Growth Rate (2017-2022)
Figure Latin America Therapeutic Nuclear Medicines Revenue and Growth Rate (2017-2022)
Figure Brazil Therapeutic Nuclear Medicines Revenue and Growth Rate (2017-2022)
Figure Mexico Therapeutic Nuclear Medicines Revenue and Growth Rate (2017-2022)
Figure Colombia Therapeutic Nuclear Medicines Revenue and Growth Rate (2017-2022)
Figure Middle East and Africa Therapeutic Nuclear Medicines Revenue and Growth Rate (2017-2022)
Figure Saudi Arabia Therapeutic Nuclear Medicines Revenue and Growth Rate (2017-2022)
Figure United Arab Emirates Therapeutic Nuclear Medicines Revenue and Growth Rate (2017-2022)
Figure Turkey Therapeutic Nuclear Medicines Revenue and Growth Rate (2017-2022)
Figure Egypt Therapeutic Nuclear Medicines Revenue and Growth Rate (2017-2022)
Figure South Africa Therapeutic Nuclear Medicines Revenue and Growth Rate (2017-2022)
Figure Nigeria Therapeutic Nuclear Medicines Revenue and Growth Rate (2017-2022)
Figure Global Therapeutic Nuclear Medicines Sales Status and Outlook (2017-2029)
Table Global Therapeutic Nuclear Medicines Sales by Player (2017-2022)
Table Global Therapeutic Nuclear Medicines Sales Share by Player (2017-2022)
Figure Global Therapeutic Nuclear Medicines Sales Share by Player in 2021
Table Therapeutic Nuclear Medicines Revenue by Player (2017-2022)
Table Therapeutic Nuclear Medicines Revenue Market Share by Player (2017-2022)
Table Therapeutic Nuclear Medicines Price by Player (2017-2022)
Table Therapeutic Nuclear Medicines Gross Margin by Player (2017-2022)
Table Therapeutic Nuclear Medicines Manufacturing Base Distribution and Sales Area by Player
Table Therapeutic Nuclear Medicines Product Type by Player
Table Mergers & Acquisitions, Expansion Plans
Figure Therapeutic Nuclear Medicines Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Market Concentration Rate of Raw Materials
Table Downstream Buyers
Figure Manufacturing Cost Structure Analysis
Table Key Raw Materials Introduction of Therapeutic Nuclear Medicines
Figure Price Trend of Key Raw Materials
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Therapeutic Nuclear Medicines Industry Development
Table Acrotech Biopharma. Profile
Table Therapeutic Nuclear Medicines Product Profiles, Application and Specification
Table Acrotech Biopharma. Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Acrotech Biopharma. Revenue and Growth Rate
Figure Acrotech Biopharma. Revenue Market Share 2017-2022
Table China Isotope and Radiation Profile
Table Therapeutic Nuclear Medicines Product Profiles, Application and Specification
Table China Isotope and Radiation Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2022)
Figure China Isotope and Radiation Revenue and Growth Rate
Figure China Isotope and Radiation Revenue Market Share 2017-2022
Table Progenics Pharmaceuticals Profile
Table Therapeutic Nuclear Medicines Product Profiles, Application and Specification
Table Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Progenics Pharmaceuticals Revenue and Growth Rate
Figure Progenics Pharmaceuticals Revenue Market Share 2017-2022
Table Novartis AG Profile
Table Therapeutic Nuclear Medicines Product Profiles, Application and Specification
Table Novartis AG Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Novartis AG Revenue and Growth Rate
Figure Novartis AG Revenue Market Share 2017-2022
Table Q BioMed Profile
Table Therapeutic Nuclear Medicines Product Profiles, Application and Specification
Table Q BioMed Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Q BioMed Revenue and Growth Rate
Figure Q BioMed Revenue Market Share 2017-2022
Table Curium Pharmaceuticals Profile
Table Therapeutic Nuclear Medicines Product Profiles, Application and Specification
Table Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Curium Pharmaceuticals Revenue and Growth Rate
Figure Curium Pharmaceuticals Revenue Market Share 2017-2022
Table Jubilant DraxImage Profile
Table Therapeutic Nuclear Medicines Product Profiles, Application and Specification
Table Jubilant DraxImage Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Jubilant DraxImage Revenue and Growth Rate
Figure Jubilant DraxImage Revenue Market Share 2017-2022
Table Bayer Profile
Table Therapeutic Nuclear Medicines Product Profiles, Application and Specification
Table Bayer Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Bayer Revenue and Growth Rate
Figure Bayer Revenue Market Share 2017-2022
Table Lantheus Profile
Table Therapeutic Nuclear Medicines Product Profiles, Application and Specification
Table Lantheus Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Lantheus Revenue and Growth Rate
Figure Lantheus Revenue Market Share 2017-2022
Table International Isotopes Profile
Table Therapeutic Nuclear Medicines Product Profiles, Application and Specification
Table International Isotopes Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2022)
Figure International Isotopes Revenue and Growth Rate
Figure International Isotopes Revenue Market Share 2017-2022
Table Dongcheng Profile
Table Therapeutic Nuclear Medicines Product Profiles, Application and Specification
Table Dongcheng Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2022)
Figure Dongcheng Revenue and Growth Rate
Figure Dongcheng Revenue Market Share 2017-2022
Table Global Therapeutic Nuclear Medicines Sales, Region Wise (2017-2022)
Table Global Therapeutic Nuclear Medicines Sales Market Share, Region Wise (2017-2022)
Figure Global Therapeutic Nuclear Medicines Sales Market Share, Region Wise (2017-2022)
Figure Global Therapeutic Nuclear Medicines Sales Market Share, Region Wise in 2021
Table Global Therapeutic Nuclear Medicines Revenue, Region Wise (2017-2022)
Table Global Therapeutic Nuclear Medicines Revenue Market Share, Region Wise (2017-2022)
Figure Global Therapeutic Nuclear Medicines Revenue Market Share, Region Wise (2017-2022)
Figure Global Therapeutic Nuclear Medicines Revenue Market Share, Region Wise in 2021
Table Global Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2022)
Table United States Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2022)
Table Europe Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2022)
Table China Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2022)
Table Japan Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2022)
Table India Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2022)
Table Southeast Asia Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2022)
Table Latin America Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2022)
Table Middle East and Africa Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2022)
Table Global Therapeutic Nuclear Medicines Sales by Type (2017-2022)
Table Global Therapeutic Nuclear Medicines Sales Market Share by Type (2017-2022)
Figure Global Therapeutic Nuclear Medicines Sales Market Share by Type in 2022
Table Global Therapeutic Nuclear Medicines Revenue by Type (2017-2022)
Table Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2017-2022)
Figure Global Therapeutic Nuclear Medicines Revenue Market Share by Type in 2022
Table Therapeutic Nuclear Medicines Price by Type (2017-2022)
Figure Global Therapeutic Nuclear Medicines Sales Growth Rate of Radium-223 (2017-2022)
Figure Global Therapeutic Nuclear Medicines Sales Growth Rate of Lutetium-177 (2017-2022)
Figure Global Therapeutic Nuclear Medicines Sales Growth Rate of Iodine-131 (2017-2022)
Figure Global Therapeutic Nuclear Medicines Sales Growth Rate of Other (2017-2022)
Table Global Therapeutic Nuclear Medicines Consumption by Application (2017-2022)
Table Global Therapeutic Nuclear Medicines Consumption Market Share by Application (2017-2022)
Table Global Therapeutic Nuclear Medicines Consumption of Thyroid (2017-2022)
Table Global Therapeutic Nuclear Medicines Consumption of Bone Metastasis (2017-2022)
Table Global Therapeutic Nuclear Medicines Consumption of Lymphoma (2017-2022)
Table Global Therapeutic Nuclear Medicines Consumption of Other (2017-2022)
Figure Global Therapeutic Nuclear Medicines Sales and Growth Rate Forecast (2022-2029)
Figure Global Therapeutic Nuclear Medicines Revenue and Growth Rate Forecast (2022-2029)
Figure Global Therapeutic Nuclear Medicines Price and Trend Forecast (2022-2029)
Figure USA Therapeutic Nuclear Medicines Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure USA Therapeutic Nuclear Medicines Market Revenue and Growth Rate Forecast Analysis (2022-2029)
Figure Europe Therapeutic Nuclear Medicines Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure Europe Therapeutic Nuclear Medicines Market Revenue and Growth Rate Forecast Analysis (2022-2029)
Figure China Therapeutic Nuclear Medicines Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure China Therapeutic Nuclear Medicines Market Revenue and Growth Rate Forecast Analysis (2022-2029)
Figure Japan Therapeutic Nuclear Medicines Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure Japan Therapeutic Nuclear Medicines Market Revenue and Growth Rate Forecast Analysis (2022-2029)
Figure India Therapeutic Nuclear Medicines Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure India Therapeutic Nuclear Medicines Market Revenue and Growth Rate Forecast Analysis (2022-2029)
Figure Southeast Asia Therapeutic Nuclear Medicines Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure Southeast Asia Therapeutic Nuclear Medicines Market Revenue and Growth Rate Forecast Analysis (2022-2029)
Figure Latin America Therapeutic Nuclear Medicines Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure Latin America Therapeutic Nuclear Medicines Market Revenue and Growth Rate Forecast Analysis (2022-2029)
Figure Middle East and Africa Therapeutic Nuclear Medicines Market Sales and Growth Rate Forecast Analysis (2022-2029)
Figure Middle East and Africa Therapeutic Nuclear Medicines Market Revenue and Growth Rate Forecast Analysis (2022-2029)
Table Global Therapeutic Nuclear Medicines Market Sales Forecast, by Type
Table Global Therapeutic Nuclear Medicines Sales Volume Market Share Forecast, by Type
Table Global Therapeutic Nuclear Medicines Market Revenue Forecast, by Type
Table Global Therapeutic Nuclear Medicines Revenue Market Share Forecast, by Type
Table Global Therapeutic Nuclear Medicines Price Forecast, by Type
Table Global Therapeutic Nuclear Medicines Market Consumption Forecast, by Application
Table Global Therapeutic Nuclear Medicines Consumption Volume Market Share Forecast, by Application
Table Global Therapeutic Nuclear Medicines Market Revenue Forecast, by Application
Table Global Therapeutic Nuclear Medicines Revenue Market Share Forecast, by Application
Table Global Therapeutic Nuclear Medicines Price Forecast, by Application